Chlorhexidine Gluconate Cloth Market Size, Share & Trends Analysis Report By Product Type (Impregnated CHG, Compatible/non-impregnated CHG), By Applications (Surgical Preparation, Personal Care, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Chlorhexidine Gluconate Cloth Market Size

The global chlorhexidine gluconate cloth market size was valued at USD 13.11 billion in 2025 and is projected to grow from USD 13.52 billion in 2026 to USD 17.33 billion by 2034, registering a CAGR of 3.15% during the forecast period from 2026 to 2034. North America dominated the chlorhexidine gluconate cloth market with a market share of 38.2% in 2025.

Chlorhexidine gluconate cloth is a medical-grade fabric infused with chlorhexidine gluconate, a chemical compound known for its powerful antimicrobial properties. It is commonly used in healthcare settings for patient preoperative skin preparation, wound cleansing, and general surface disinfection. Chlorhexidine gluconate disrupts the cell membranes of microorganisms, effectively killing bacteria, viruses, and fungi on contact.

The cloth format provides a convenient and effective means of delivering the chlorhexidine solution to targeted areas, ensuring thorough disinfection without additional liquids or messy applications. Its broad-spectrum activity and residual effects make it a preferred choice in infection control protocols. However, following proper usage guidelines and precautions is essential to avoid skin irritation or other negative reactions. North America is estimated to be the largest market shareholder.

Product Type Insights

The impregnated cloth segment within the chlorhexidine gluconate (CHG) cloth market offers a convenient and effective solution for healthcare facilities seeking standardized preoperative skin preparation and catheter site care. These cloths are pre-saturated with a precise concentration of chlorhexidine gluconate solution, ensuring uniform distribution of the antimicrobial agent on the skin surface. The impregnated cloths simplify the application process, saving time and reducing the risk of dosage errors. Healthcare providers appreciate the consistency and reliability offered by impregnated cloths, which contribute to enhanced patient safety and infection prevention practices. Moreover, impregnated cloths are available in various sizes and configurations to accommodate different procedural needs, making them versatile in hospitals, clinics, and ambulatory surgical centers. Thus, the impregnated cloth segment addresses the demand for convenient and standardized infection control solutions in healthcare settings.

Request Customizationto receive a tailored report.

Application Insights

The surgical preparation segment within the chlorhexidine gluconate (CHG) cloth market ensures patient safety and reduces the risk of surgical site infections (SSIs). CHG cloths are extensively used in this application to achieve optimal skin disinfection before surgical procedures. These cloths contain a precise chlorhexidine gluconate solution concentration, effectively eliminating resident and transient microorganisms from the patient's skin surface. By removing dirt, oil, and bacteria, CHG cloths create a sterile field that minimizes the risk of contamination during surgery. Healthcare providers favor CHG cloths for preoperative skin preparation due to their ease of use, consistency, and proven efficacy in reducing SSIs. This segment caters to healthcare facilities' stringent infection control requirements, enhancing patient outcomes and promoting surgical safety protocols.

End-Users Insights

The hospitals segment constitutes a significant portion of the chlorhexidine gluconate (CHG) cloth market, driven by the widespread adoption of infection control measures and the high volume of surgical operations conducted in hospital settings. Hospitals rely on CHG cloths for preoperative skin preparation, catheter site care, and other infection prevention protocols to mitigate the risk of healthcare-associated infections (HAIs). CHG cloths play a crucial role in maintaining a sterile environment during surgeries, reducing the incidence of surgical site infections (SSIs) and catheter-related bloodstream infections (CRBSIs). Healthcare professionals in hospitals value the convenience, effectiveness, and consistency CHG cloths offer in promoting patient safety and enhancing surgical outcomes. Moreover, stringent regulatory standards and infection control guidelines mandate the use of CHG cloths in hospitals, further driving market growth within this segment.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global chlorhexidine gluconate cloth market shareholder and is expected to expand substantially during the forecast period. North America is prominent in the chlorhexidine gluconate (CHG) cloth market, driven by advanced healthcare infrastructure and rigorous infection control standards. The region's robust regulatory framework, spearheaded by agencies like the U.S. Food and Drug Administration (FDA), ensures the quality and safety of medical devices, including CHG cloths. Moreover, the key players are launching new products approved by these regulatory bodies, thereby boosting market expansion.

• For instance, in February 2019, Medline introduced its new FDA-approved ReadyPrepTM CHG cloths, which are pre-soaked with a 2 percent solution of chlorhexidine gluconate. This release marks Medline's initial foray into the CHG cloth market, providing a new option for patient preoperative skin preparation as an alternative to the existing CHG-impregnated cloths.

Furthermore, the rising incidence of HAIs and the escalating volume of surgical procedures are anticipated to drive the demand for CHG clothes owing to their potent disinfectant capabilities. According to the Massachusetts Health & Hospital Association, Inc., the Centers for Disease Control and Prevention (CDC) has estimated that approximately 1.7 million healthcare-related diseases and 99,000 associated deaths occur annually in hospitals in the United States. Thus, the increase in hospital admissions of patients due to healthcare-associated infections (HAIs) contributes to the growth of the regional market.

Unlock Regional Insightsto access country-level data, & regional trends.

The Asia-Pacific region is witnessing rapid development in the chlorhexidine gluconate (CHG) cloth market,driven by increasing healthcare expenditure, expanding medical tourism, and improving healthcare infrastructure. Nations like China and India are at the forefront of this growth, supported by rising awareness about infection control practices and the growing prevalence of surgical procedures. Similarly, government initiatives aimed at enhancing healthcare facilities and promoting patient safety further contribute to regional market expansion.

• For instance, the Ayushman Bharat initiative, launched by the Indian government in 2018, aims to provide health insurance coverage to 500 million individuals nationwide. Moreover, the Asia-Pacific market presents lucrative opportunities for CHG cloth manufacturers, with favorable demographic trends and a rising focus on enhancing healthcare quality and outcomes.

List of Key and Emerging Players in Chlorhexidine Gluconate Cloth Market